NASDAQ:INNV InnovAge (INNV) Stock Price, News & Analysis $9.10 -0.02 (-0.22%) Closing price 10/28/2026 04:00 PM EasternExtended Trading$9.10 0.00 (-0.05%) As of 10/28/2026 04:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About InnovAge Stock (NASDAQ:INNV) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get InnovAge alerts:Sign Up Key Stats Today's Range$9.04▼$9.3850-Day Range$8.80▼$11.0452-Week Range$3.93▼$12.64Volume475,986 shsAverage Volume377,313 shsMarket Capitalization$1.24 billionP/E RatioN/ADividend YieldN/APrice Target$10.50Consensus RatingReduce Company Overview InnovAge (NASDAQ: INNV) is a healthcare services company that provides comprehensive care for older adults through the Program of All-Inclusive Care for the Elderly (PACE). Its model is designed to help eligible seniors remain living in their homes and communities rather than moving to nursing facilities, while coordinating medical, social, and supportive services through an integrated care program. InnovAge’s services may include primary and specialty medical care, nursing, physical and occupational therapy, behavioral health, pharmacy services, dentistry, vision care, meals, transportation, social services, and in-home support. Care is delivered through community-based PACE centers and participants’ residences, with services coordinated by interdisciplinary care teams. The company traces its origins to 1997 and operates PACE programs in Colorado and California. InnovAge became a publicly traded company in 2021. Its programs generally serve older adults who meet applicable age, health, and eligibility requirements for PACE, with funding and coverage typically involving Medicare, Medicaid, or private-pay arrangements depending on the participant and program.AI Generated. May Contain Errors. Read More InnovAge Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks60th Percentile Overall ScoreINNV MarketRank™: 3.02028161736 of 5 starsInnovAge scored higher than 60% of companies evaluated by MarketBeat, and ranked 373rd out of 903 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.5 / 5Analyst RatingReduce Consensus RatingInnovAge has received a consensus rating of Reduce. The company's average rating score is 1.75, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and 2 sell ratings.Upside PotentialInnovAge has a consensus price target of $10.50, representing about 15.4% upside from its current price of $9.10.Amount of Analyst CoverageInnovAge has only been the subject of 2 research reports in the past 90 days.Read more about InnovAge's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth11.63% Earnings GrowthEarnings for InnovAge are expected to grow by 11.63% in the coming year, from $0.43 to $0.48 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of InnovAge is -455.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of InnovAge is -455.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioInnovAge has a P/B Ratio of 5.17. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about InnovAge's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.85% of the float of InnovAge has been sold short.Short Interest Ratio / Days to CoverInnovAge has a short interest ratio ("days to cover") of 2.06, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in InnovAge has recently decreased by 57.00%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldInnovAge does not currently pay a dividend.Dividend GrowthInnovAge does not have a long track record of dividend growth. News and Social Media3.6 / 5News Sentiment0.73 News SentimentInnovAge has a news sentiment score of 0.73. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 13 news articles for InnovAge this week, compared to 3 articles on an average week.Search Interest2 people have searched for INNV on MarketBeat in the last 30 days. MarketBeat Follows3 people have added InnovAge to their MarketBeat watchlist in the last 30 days. Company Ownership0.9 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, InnovAge insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $120,489,535.00 in company stock.Percentage Held by Insiders1.00% of the stock of InnovAge is held by insiders.Percentage Held by Institutions12.26% of the stock of InnovAge is held by institutions.Read more about InnovAge's insider trading history. Receive INNV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InnovAge and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. INNV Stock News HeadlinesInnovAge (NASDAQ:INNV) Insider Nicole Damato Sells 3,402 Shares of Company StockOctober 27 at 4:22 AM | insidertrades.comInnovAge (NASDAQ:INNV) Major Shareholder Sells $13,875,000.00 in StockOctober 24, 2026 | insidertrades.comManagement just bought 2.8 million sharesManagement just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 in one quarter. Institutions own about 83% of shares, including BlackRock's 32 million shares worth $716 million and Vanguard's 48 million shares worth nearly $1.1 billion. A new multi-year deal with Palantir adds an AI-driven edge to this energy producer's operations. | Monument Traders Alliance (Ad)InnovAge Holding Corp. ($INNV) CEO 2026 Pay RevealedOctober 22, 2026 | quiverquant.comQInnovAge : Leaders Share PACE Expertise and Innovation at National PACE Association ConferenceOctober 22, 2026 | marketscreener.comMInnovAge to Announce Fiscal First Quarter 2027 Financial Results and Host Conference Call Tuesday, November 3, 2026October 20, 2026 | globenewswire.comInnovAge (NASDAQ:INNV) Insider Sells $207,181.80 in StockSeptember 30, 2026 | insidertrades.comInsider Selling: InnovAge (NASDAQ:INNV) Major Shareholder Sells 10,000,000 Shares of StockSeptember 29, 2026 | insidertrades.comSee More Headlines INNV Stock Analysis - Frequently Asked Questions How have INNV shares performed this year? InnovAge's stock was trading at $5.19 at the start of the year. Since then, INNV stock has increased by 75.3% and is now trading at $9.10. How were InnovAge's earnings last quarter? InnovAge Holding Corp. (NASDAQ:INNV) issued its quarterly earnings results on Tuesday, September, 8th. The company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.07 by $0.01. The company had revenue of $261.95 million for the quarter, compared to analyst estimates of $238.33 million. InnovAge had a negative trailing twelve-month return on equity of 1.03% and a negative net margin of 0.26%. Read the conference call transcript. When did InnovAge IPO? InnovAge (INNV) raised $342 million in an initial public offering (IPO) on Thursday, March 4th 2021. The company issued 16,666,667 shares at a price of $20.00-$21.00 per share. J.P. Morgan, Barclays, Goldman Sachs and Citigroup served as the underwriters for the IPO and Baird, William Blair, Piper Sandler, Capital One Securities, Loop Capital Markets, Siebert Williams Shank and Roberts & Ryan were co-managers. Who are InnovAge's major shareholders? Top institutional shareholders of InnovAge include Argent Capital Management LLC (0.05%). Insiders that own company stock include Carson Anderson & Stow Welsh, Aggregator Lp Ignite, Nicole Damato, Michael Anthony Scarbrough, Richard C Zoretic and Richard C Zoretic. View institutional ownership trends. How do I buy shares of InnovAge? Shares of INNV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of InnovAge own? Based on aggregate information from My MarketBeat watchlists, some other companies that InnovAge investors own include Walt Disney (DIS), NVIDIA (NVDA), Visa (V), Energy Transfer (ET), American International Group (AIG), Blackstone (BX) and Enterprise Products Partners (EPD). Company Calendar Last Earnings9/08/2026Today10/28/2026Next Earnings (Estimated)11/03/2026Fiscal Year End6/30/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (4m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 INNV's financial health is in the Green zone, according to TradeSmith. INNV has been in this zone for over 4 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNASDAQ:INNV Previous SymbolOTCMKTS:INNV CIK1834376 Webwww.innovage.com Phone844-803-8745FaxN/AEmployees2,500Year Founded1990Price Target and Rating Average Price Target for InnovAge$10.50 High Price Target$14.00 Low Price Target$7.00 Potential Upside/Downside+15.4%Consensus RatingReduce Rating Score (0-4)1.75 Research Coverage4 Analysts Profitability EPS (Trailing Twelve Months)($0.02) Trailing P/E RatioN/A Forward P/E Ratio21.16 P/E GrowthN/ANet Income-$2.54 million Net Margins-0.26% Pretax Margin0.03% Return on Equity-1.03% Return on Assets-0.47% Debt Debt-to-Equity Ratio0.23 Current Ratio1.05 Quick Ratio1.05 Sales & Book Value Annual Sales$989.71 million Price / Sales1.25 Cash Flow$0.14 per share Price / Cash Flow66.90 Book Value$1.76 per share Price / Book5.17Miscellaneous Outstanding Shares136,460,000Free Float135,092,000Market Cap$1.24 billion OptionableOptionable Beta0.15 Social Links 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (NASDAQ:INNV) was last updated on 10/28/2026 by MarketBeat.com Staff. From Our PartnersThe cash in your checking account has a problemThere's a pile of cash sitting in your checking account, earning next to nothing while you weigh your options....Counterflow | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredA free stock pick, from me to youElon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Withou...Behind the Markets | SponsoredManagement just bought 2.8 million sharesManagement just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 i...Monument Traders Alliance | SponsoredA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredDon't lose access to thisIan Cooper's guide, 'The $50-to-$500 Options Strategy,' is still available for free download, but not for long...TradeWins | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InnovAge Holding Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share InnovAge With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
